On March 5, 2024, Orgenesis Inc. closed the transaction. The company received $2,340,903 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 46 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 USD | -1.03% | -13.07% | -4.13% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-4.13% | 16.54M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.57B | |
+2.64% | 49.95B | |
+6.58% | 43.84B | |
+4.91% | 41.71B | |
+21.98% | 31.59B | |
+14.45% | 25.3B | |
-5.81% | 23.94B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it has received $2.340901 million in funding